Literature DB >> 17564317

Effects of diode 808 nm GaAlAs low-power laser irradiation on inhibition of the proliferation of human hepatoma cells in vitro and their possible mechanism.

Yi-Hsiang Liu1, Chiung-Chi Cheng, Chin-Chin Ho, Ren-Jeng Pei, Karen Ying Lee, Kun-Tu Yeh, You Chan, Yih-Shyong Lai.   

Abstract

Low-power laser irradiation (LPLI) has come into a wide range of use in medical field. Considering basic research, LPLI can enhance DNA synthesis and increases proliferation rate of human cells. But only a few data about the effects of LPLI on human liver or hepatoma cells are available. The cytoskeleton plays important roles in cell function and therefore is implicated in the pathogenesis of many human liver diseases, including malignant tumors. In our previous study, we found the stability of cytokeratin molecules in human hepatocytes was related to the intact microtubule network that was influenced by colchicine. In this study, we are going to search the effect of LPLI on proliferation of human hepatoma cell line HepG2 and J-5 cells. In addition, the stability of cytokeratin and synemin (one of the intermediate filament-associated proteins) were analyzed under the action of LPLI to evaluate the possible mechanism of LPLI effects on proliferation of human hepatoma cells. In experiment, HepG2 and J-5 cells were cultured in 24-well plate for 24 hours. After irradiation by 130 mW diode 808 nm GaAlAs continue wave laser in different time intervals, the cell numbers were counted. Western blot and immunofluorescent staining examined the expression and distribution of PCNA, cytokeratin and synemin. The cell number counting and PCNA expression were evaluated to determine the proliferation. The organization and expression of cytokeratin and synemin were studied to identify the stability of cytoskeleton affected by LPLI. The results revealed that proliferation of HepG2 and J-5 cells was inhibited by LPLI since the cell number and PCNA expression was reduced. Maximal effect was achieved with 90 and 120 seconds of exposure time (of energy density 5.85 J/cm2 and 7.8 J/cm2, respectively) for HepG2 and J-5, respectively. The decreased ratio of cell number by this dose of irradiation was 72% and 66% in HepG2 and J-5 cells, respectively. Besides that, the architecture of intermediate filaments in these cells was disorganized by laser irradiation. The expression of intermediate filament-associated protein, synemin, was also reduced. Two significant findings are raised in this study: (1) Diode 808 nm GaAlAs continuous wave laser has an inhibitory effect on the proliferation of human hepatoma cells line HepG2 and J-5. (2) The mechanism of inhibition might be due to down-regulation of synemin expression and alteration of cytokeratin organization that was caused by laser irradiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 17564317

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  10 in total

1.  Photobiomodulation effects on head and neck squamous cell carcinoma (HNSCC) in an orthotopic animal model.

Authors:  Andrei Barasch; Hongyan Li; Vinagolu K Rajasekhar; Judith Raber-Durlacher; Joel B Epstein; James Carroll; Adriana Haimovitz-Friedman
Journal:  Support Care Cancer       Date:  2019-11-08       Impact factor: 3.603

2.  The effects of 808-nm near-infrared laser light irradiation on actin cytoskeleton reorganization in bone marrow mesenchymal stem cells.

Authors:  Andrea Amaroli; Maria Giovanna Sabbieti; Luigi Marchetti; Angelina O Zekiy; Anatoliy S Utyuzh; Andrea Marchegiani; Fulvio Laus; Vincenzo Cuteri; Stefano Benedicenti; Dimitrios Agas
Journal:  Cell Tissue Res       Date:  2020-11-07       Impact factor: 5.249

Review 3.  Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations.

Authors:  Judith A E M Zecha; Judith E Raber-Durlacher; Raj G Nair; Joel B Epstein; Stephen T Sonis; Sharon Elad; Michael R Hamblin; Andrei Barasch; Cesar A Migliorati; Dan M J Milstein; Marie-Thérèse Genot; Liset Lansaat; Ron van der Brink; Josep Arnabat-Dominguez; Lisette van der Molen; Irene Jacobi; Judi van Diessen; Jan de Lange; Ludi E Smeele; Mark M Schubert; René-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2016-03-16       Impact factor: 3.603

4.  Low-level laser therapy promotes proliferation and invasion of oral squamous cell carcinoma cells.

Authors:  Águida Cristina Gomes Henriques; Fernanda Ginani; Ruth Medeiros Oliveira; Tatjana Souza Lima Keesen; Carlos Augusto Galvão Barboza; Hugo Alexandre Oliveira Rocha; Jurema Freire Lisboa de Castro; Ricardo Della Coletta; Roseana de Almeida Freitas
Journal:  Lasers Med Sci       Date:  2014-02-14       Impact factor: 3.161

5.  Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway.

Authors:  Felipe F Sperandio; Fernanda S Giudice; Luciana Corrêa; Décio S Pinto; Michael R Hamblin; Suzana C O M de Sousa
Journal:  J Biophotonics       Date:  2013-04-02       Impact factor: 3.207

6.  Percutaneous Exposures of volunteers to polychromatic light (480-3400 nm) trigger systemic mechanism of the human myeloma cells growth delay without any effect on bortezomib cytotoxicity in vitro.

Authors:  Natalia V Kalmykova; Anna V Shcherbanyuk; Sergei I Moiseev; Natalia V Bichkova; Natalia I Davidova; Kira A Samoilova
Journal:  Laser Ther       Date:  2019-09-30

7.  Photoradiation could influence the cytoskeleton organization and inhibit the survival of human hepatoma cells in vitro.

Authors:  Yi-Hsiang Liu; Chin-Chin Ho; Chiung-Chi Cheng; Yung-Hsiang Hsu; Yih-Shyong Lai
Journal:  Lasers Med Sci       Date:  2006-03-29       Impact factor: 2.555

8.  Synemin: an evolving role in tumor growth and progression.

Authors:  Shailendra Kapoor
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-05-28       Impact factor: 12.910

9.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Authors:  Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 10.  Safety and efficacy of photobiomodulation therapy in oncology: A systematic review.

Authors:  René-Jean Bensadoun; Joel B Epstein; Raj G Nair; Andrei Barasch; Judith E Raber-Durlacher; Cesar Migliorati; Marie-Thérèse Genot-Klastersky; Nathaniel Treister; Praveen Arany; Joy Lodewijckx; Jolien Robijns
Journal:  Cancer Med       Date:  2020-10-26       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.